A Jarfaut, R Santucci, D Levêque, R Herbrecht. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAnti-Bacterial Agents/adverse effectsAnti-Bacterial Agents/chemistryAnti-Bacterial Agents/therapeutic useAntifungal Agents/therapeutic useAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useAntiviral Agents/therapeutic useBicarbonates/adverse effectsBicarbonates/therapeutic useBleomycin/administration & dosageCiprofloxacin/adverse effectsCiprofloxacin/chemistryCiprofloxacin/therapeutic useCrystallizationCyclophosphamide/administration & dosageCytarabine/administration & dosageDiarrhea/chemically inducedDoxorubicin/administration & dosageDrug Eruptions/etiologyDrug InteractionsEtoposide/administration & dosageFemaleFluid TherapyFungemia/complicationsFungemia/drug therapyHumansHydrogen-Ion ConcentrationIfosfamide/administration & dosageLymphoma, B-Cell/drug therapyMediastinal Neoplasms/drug therapyMetabolic Clearance Rate/drug effectsMethotrexate/administration & dosageMethotrexate/adverse effectsMethotrexate/bloodMethotrexate/pharmacokineticsMucositis/chemically inducedPancytopenia/chemically inducedPrednisone/administration & dosageSolubilityUrine/chemistryVindesine/administration & dosage
Substances： See more » Anti-Bacterial AgentsAntifungal AgentsAntiviral AgentsBicarbonatesCytarabineBleomycinCiprofloxacinEtoposideDoxorubicinCyclophosphamideVindesineIfosfamidePrednisoneMethotrexate
Year: 2013 PMID： 23332768 DOI： 10.1016/j.medmal.2012.11.006
Source DB: PubMed Journal: Med Mal Infect ISSN： 0399-077X Impact factor: 2.152